Company Number: 15219187

Analysis Date: 2025-07-29 12:59 UTC

Financial Health Assessment Report: XOLXOL PHARMA LTD

---

1. Financial Health Score: B

Explanation:
XOLXOL PHARMA LTD demonstrates a solid foundation typical for a newly incorporated micro-entity. The company shows positive net assets and healthy working capital, indicating good initial financial stability. However, due to its recent formation and limited operational history (less than one full financial year), the full financial trajectory is yet to be proven, preventing a higher grade at this early stage.

---

2. Key Vital Signs

Metric	Value	Interpretation
Fixed Assets	£720	Very low fixed asset base, typical for a startup; no heavy investment in property or equipment yet.
Current Assets	£9,235	Positive current assets primarily likely cash or receivables, indicating liquidity.
Current Liabilities	£4,105	Short-term obligations are modest, manageable relative to current assets.
Net Current Assets (Working Capital)	£5,130	Healthy positive working capital; the company can cover its short-term debts comfortably.
Total Net Assets (Equity)	£5,850	Positive net worth showing shareholders’ funds exceed liabilities.
Employees	0	No employees currently engaged, indicating minimal operational expenses and overhead.

Interpretation:
The company’s balance sheet shows a "healthy pulse" with liquidity sufficient to meet short-term obligations, reflecting no immediate cash flow distress. The lack of employees suggests the company is either in a preparatory phase or operating with minimal staff, which reduces burn rate but also means limited operational activity so far.

---

3. Diagnosis

Overall Financial Condition:
XOLXOL PHARMA LTD is in the early stages of its life cycle, showing "healthy vital signs" for a micro-entity startup. The positive net assets and working capital indicate no symptoms of financial distress or insolvency risk at this point. The small asset base and lack of employees suggest the company is in a setup or incubation phase, possibly focusing on establishing market presence or awaiting operational scaling.

Potential Risks and Considerations:

• The short operating history means limited financial data to assess profitability or cash flow sustainability.
• No audit requirement under micro-entity exemption; while common for companies of this size, it limits external assurance on financial accuracy.
• The company is 100% controlled by a single director/shareholder, which places decision-making and financial health heavily on one individual’s actions and strategy.

---

4. Recommendations

To enhance financial wellness and support future growth, consider the following:

1. Cash Flow Monitoring:
   Establish a detailed cash flow forecast to anticipate liquidity needs as operations scale. Healthy cash flow is essential to avoid "symptoms of distress" such as delayed payments or forced borrowing.

2. Build Operational Capacity:
   Plan for incremental hiring or outsourcing to support business activities, ensuring operational demands do not outpace financial resources.

3. Financial Planning and Reporting:
   Even though audit exemption applies, maintain robust internal records and consider periodic external reviews to build stakeholder confidence.

4. Risk Management:
   As a single-controller entity, consider corporate governance best practices to mitigate risks associated with key person dependency.

5. Growth Strategy:
   Develop a clear strategic plan for market entry and revenue generation aligned with the capital base to ensure sustainability beyond the startup phase.

---